Skip to Main Content
The first stop for professional medicines advice

Training and Development

83 results

Applied filters

Supporting people with sight loss in managing their medicines

20 March 2025Guidance for pharmacy staff about how to support people with sight loss in using their medicines and accessing pharmacy services.

Tools to support medication review

21 July 2026These practical tools aid medication review by identifying inappropriate medicines, guiding deprescribing, and empowering patients via shared decision making.

A person-centred approach to polypharmacy and medication review

5 February 2026This article outlines how to identify, invite and apply a person-centred framework to support structured medication review.

Understanding polypharmacy, overprescribing and deprescribing

21 July 2026We explore the causes, consequences and tools to support pharmacy professionals in managing polypharmacy, overprescribing and deprescribing in practice.

Resources to support medication review

24 July 2026These resources provide information and guidance that reflects the growing understanding of problematic polypharmacy and overprescribing.

Liver disease podcast series

16 December 2025Pharmacy colleagues and expert clinical speakers talk about liver disease and drugs in liver impairment.

Pharmacy technician coffee break conversation podcasts

25 July 2024A series of short podcast discussions with pharmacy technicians about their roles and the different ways they provide patient care.

Information resources for advice on HRT

26 June 2024SPS and other information resources to help healthcare professionals provide advice on the menopause and hormone replacement therapy (HRT) decision making.

Understanding enzyme or transporter-based drug interactions

5 July 2024Many interactions are due to inhibition or induction of metabolising enzymes or drug transporters. Enzyme, transporter, and drug half-lives dictate duration.

Calculating and using the Child-Pugh score

14 June 2024The Child-Pugh score is used to estimate the severity of liver disease in patients with cirrhosis, and by drug manufacturers to suggest dose adjustments.